Evidence map›Paper›PMID 41117878›Full record

ArticleJournal of clinical immunology2025

Beyond the Classical Triad: Atypical Presentations and Regulatory T Cell Phenotyping in a Cohort of IPEX Patients.

Ismail Yaz, Sevil Oskay Halacli, Canberk Ipsir, Baris Ulum, Elif Soyak Aytekin, Hacer Neslihan Bildik, Melike Ocak, Hanife Avci, Fatma Visal Okur, Hayriye Hizarcioglu Gulsen and 7 more

Abstract read
In one paragraph

Article in Journal of clinical immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Ismail YazDivision of Immunology, Department of Pediatric Basic Sciences, Institute of Child Health, Hacettepe University, Ankara, Turkey.
Sevil Oskay HalacliDivision of Immunology, Department of Pediatric Basic Sciences, Institute of Child Health, Hacettepe University, Ankara, Turkey.
Canberk IpsirDivision of Immunology, Department of Pediatric Basic Sciences, Institute of Child Health, Hacettepe University, Ankara, Turkey.
Baris UlumIhsan Dogramaci Children's Hospital, Hacettepe University, Ankara, Turkey.
Elif Soyak AytekinIhsan Dogramaci Children's Hospital, Hacettepe University, Ankara, Turkey.
Hacer Neslihan BildikDivision of Immunology, Department of Pediatric Basic Sciences, Institute of Child Health, Hacettepe University, Ankara, Turkey.
Melike OcakIhsan Dogramaci Children's Hospital, Hacettepe University, Ankara, Turkey.
Hanife AvciDepartment of Biostatistics, Hacettepe University Medical School, Ankara, Turkey.
Fatma Visal OkurIhsan Dogramaci Children's Hospital, Hacettepe University, Ankara, Turkey.
Hayriye Hizarcioglu GulsenIhsan Dogramaci Children's Hospital, Hacettepe University, Ankara, Turkey.
Hulya DemirIhsan Dogramaci Children's Hospital, Hacettepe University, Ankara, Turkey.
Ayse MetinDepartment of Pediatric Immunology and Allergy, University of Health Sciences, Bilkent City Hospital, Ankara, Turkey.
Alev OzonIhsan Dogramaci Children's Hospital, Hacettepe University, Ankara, Turkey.
Baris KuskonmazIhsan Dogramaci Children's Hospital, Hacettepe University, Ankara, Turkey.
Ilhan TezcanDivision of Immunology, Department of Pediatric Basic Sciences, Institute of Child Health, Hacettepe University, Ankara, Turkey.
Saliha EsenbogaIhsan Dogramaci Children's Hospital, Hacettepe University, Ankara, Turkey.
Deniz CagdasDivision of Immunology, Department of Pediatric Basic Sciences, Institute of Child Health, Hacettepe University, Ankara, Turkey. deniz.ayvaz@hacettepe.edu.tr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundImmune dysregulation, polyendocrinopathy, enteropathy, and X-linked(IPEX) syndrome caused by FOXP3 mutations is rare. FOXP3 is a transcription factor required for the regulatory T cell (Treg) development/function.

aimWe aimed to characterize the clinical, immunologic, and genetic features of a single-center cohort of IPEX syndrome. PATIENTS AND

methodsWe present the clinical/immunological/genetic features of 12 patients with IPEX syndrome. We used whole exome and Sanger sequencing for the diagnosis/familial segregation. We performed immunophenotyping and measured Treg percentage and FOXP3 expression in peripheral blood by flow cytometric analysis.

resultsMedian age at diagnosis was 2.5 years (range: 0.3-22 years). Common clinical manifestations were infections (n = 9, 75%), allergies (n = 8, 67%), autoimmunity (n = 7, 58%), enteropathy (n = 7, 58%), and lymphoproliferation (n = 3, 25%). Atypical initial presentations included class IV lupus nephritis, a SCID-like immunophenotype (CD3

conclusionAtypical presentations make the diagnosis of IPEX syndrome challenging. This study expands the current knowledge of IPEX syndrome by describing a single-center cohort with certain atypical manifestations and by confirming previously reported rare phenotypes. Elucidating the genetic basis of immunodeficiency diseases contributes to improving diagnostic approaches and patient management.

Indexed as

Diabetes Mellitus, Type 1DiarrheaForkhead Transcription FactorsGenetic Diseases, X-LinkedImmune System DiseasesT-Lymphocytes, RegulatoryAdolescentAdultChildChild, PreschoolCohort StudiesFemaleHumansImmunophenotypingInfantMaleForkhead Transcription FactorsFOXP3 protein, humanFOXP3IPEXTREGWES

Identifiers

PMID41117878
PMCPMC12540517

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.